1. Home
  2. TSLX vs BHVN Comparison

TSLX vs BHVN Comparison

Compare TSLX & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TSLX
  • BHVN
  • Stock Information
  • Founded
  • TSLX 2010
  • BHVN 2013
  • Country
  • TSLX United States
  • BHVN United States
  • Employees
  • TSLX N/A
  • BHVN N/A
  • Industry
  • TSLX Investment Managers
  • BHVN Biotechnology: Pharmaceutical Preparations
  • Sector
  • TSLX Finance
  • BHVN Health Care
  • Exchange
  • TSLX Nasdaq
  • BHVN Nasdaq
  • Market Cap
  • TSLX 1.9B
  • BHVN 1.9B
  • IPO Year
  • TSLX 2014
  • BHVN 2017
  • Fundamental
  • Price
  • TSLX $20.43
  • BHVN $20.37
  • Analyst Decision
  • TSLX Strong Buy
  • BHVN Strong Buy
  • Analyst Count
  • TSLX 6
  • BHVN 14
  • Target Price
  • TSLX $23.17
  • BHVN $63.15
  • AVG Volume (30 Days)
  • TSLX 649.9K
  • BHVN 1.7M
  • Earning Date
  • TSLX 04-30-2025
  • BHVN 05-08-2025
  • Dividend Yield
  • TSLX 10.28%
  • BHVN N/A
  • EPS Growth
  • TSLX N/A
  • BHVN N/A
  • EPS
  • TSLX 2.03
  • BHVN N/A
  • Revenue
  • TSLX $482,526,000.00
  • BHVN N/A
  • Revenue This Year
  • TSLX N/A
  • BHVN N/A
  • Revenue Next Year
  • TSLX $0.65
  • BHVN $65.26
  • P/E Ratio
  • TSLX $10.08
  • BHVN N/A
  • Revenue Growth
  • TSLX 10.14
  • BHVN N/A
  • 52 Week Low
  • TSLX $18.58
  • BHVN $15.79
  • 52 Week High
  • TSLX $23.67
  • BHVN $55.70
  • Technical
  • Relative Strength Index (RSI)
  • TSLX 41.67
  • BHVN 39.78
  • Support Level
  • TSLX $19.29
  • BHVN $15.79
  • Resistance Level
  • TSLX $20.36
  • BHVN $19.30
  • Average True Range (ATR)
  • TSLX 0.75
  • BHVN 2.20
  • MACD
  • TSLX -0.06
  • BHVN 0.26
  • Stochastic Oscillator
  • TSLX 45.68
  • BHVN 42.84

About TSLX Sixth Street Specialty Lending Inc.

Sixth Street Specialty Lending Inc is a specialty finance company focused on providing flexible, fully committed financing solutions to middle market companies located in the United States of America. It partners with companies across a variety of industries and excel at providing creative solutions to companies with complex business models that may have limited access to capital. The company seeks to generate current income in U.S.-domiciled middle-market companies through direct originations of senior secured loans and, to a lesser extent, originations of mezzanine and unsecured loans and investments in corporate bonds and equity securities.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

Share on Social Networks: